FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Primary Sjögren's syndrome patients' B-Cell Stimulating Factors are associated with the growth of lymphomas.

2.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

3.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

4.

Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic

5.

New imaging guidelines for head and neck cancers, a step toward practice change


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot